Breast cancer surveillance for BRCA1/2 mutation carriers – is “early detection” early enough?
暂无分享,去创建一个
E. Friedman | B. Kaufman | Y. Laitman | M. Sklair-Levy | R. Bernstein-Molho | D. Zippel | D. Feldman | M. B. Ben David | E. Friedman
暂无分享,去创建一个
E. Friedman | B. Kaufman | Y. Laitman | M. Sklair-Levy | R. Bernstein-Molho | D. Zippel | D. Feldman | M. B. Ben David | E. Friedman